Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 2

2(28.6%)

Phase 4

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(3)

Phase 2(2)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05531773Recruiting

Post COVID-19 Condition

Role: collaborator

NCT03041012Phase 2Completed

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Role: collaborator

NCT04722757Not ApplicableUnknown

Comparison of Functional Outcomes Between Transanal and Laparoscopic vs Open Ileal Pouch-Anal Anastomosis

Role: collaborator

NCT03065660Phase 3Completed

Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage

Role: collaborator

NCT04062539Suspended

Total Cerebral Protection With Embolic Protection Devices Thoracic Aortic Stenting

Role: collaborator

NCT03040570Not ApplicableCompleted

Conservative Versus Liberal Oxygenation Targets in Critically Ill Children

Role: collaborator

NCT01188941Not ApplicableCompleted

Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa

Role: collaborator

NCT01692093Phase 2Unknown

KM110329 in Adult Patients With Atopic Dermatitis

Role: collaborator

NCT00840008Phase 4Completed

The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding

Role: collaborator

All 9 trials loaded